The results show that the expression levels of TLR4, IL6 and CCL2 varied between human HCC samples, indicating that the upregulation of TLR4, IL6 and CCL2 might not be a typical event in the early stages of HCC (stage I or II) (Supplementary Figure S1). The gene discussed is TLR4; the disease is hepatocellular carcinoma.